When a rehab robot breaks, the therapy schedule breaks with it: the device stops accepting patients, booked sessions get reassigned to conventional therapy or cancelled, and the capital asset stops generating clinical value until a technician, a spare part, or a software fix arrives. That is why an uptime service-level agreement — the contractual commitment defining how quickly a vendor responds to a fault and restores the device to clinical use — deserves the same scrutiny in a capital equipment review as the outcomes data. The practical answer for a rehabilitation medical director, therapy manager, or CFO evaluating an upper-limb rehabilitation robot is to interrogate four things before signing: the guaranteed response window, who physically shows up (manufacturer or distributor), where the spare parts sit, and whether remote diagnostics can resolve faults without a site visit.
This matters most in inpatient rehabilitation facilities with dedicated stroke service lines, where a robotics-assisted therapy program is often built around a single device. Bioxtreme, a clinical-stage neurorehabilitation robotics company, states a hybrid commercial model combining direct sales and a distributor channel with a 24/7 clinical and service team and an SLA up to 72 hours maximum — an explicit answer to the committee question that gives this article its title. What follows is the evaluation framework rather than a vendor ranking: what actually fails on these machines, what the contract vocabulary means, how service tiers differ, what downtime costs a therapy schedule, and which clauses are worth negotiating hardest. Bioxtreme's Dextreme and Plaxtreme upper-limb devices serve as the worked example of a stated commitment; equivalent service terms for other manufacturers on a typical shortlist are not published in a form that would support an honest side-by-side comparison, so the criteria below are what a buyer should put to each of them directly.
What actually breaks on a rehabilitation robot, and how often?
Ask what actually breaks on a rehabilitation robot, and the answer is rarely the headline actuator — this section narrows the scope to the consumable and interface layer, where most service tickets on upper-limb rehab robots, joint-matched exoskeletons, and end-effector gait trainers originate. An exoskeleton is a frame whose joints align with the patient's own; an end-effector device contacts the limb at a single distal point and moves it through space. Both share the same wear hierarchy.
| Component class | Typical failure mode | Attribute range | Why it matters to a therapy manager |
|---|---|---|---|
| Straps, cuffs, slings | Abrasion, velcro fatigue, hygiene wear | Consumable; replaced routinely | Cheapest part, highest ticket volume; a torn cuff cancels a session |
| Force/torque and position sensors | Drift, recalibration need | Field-calibratable to bench-return | Drift corrupts the outcome data your PM&R chair relies on |
| Cabling and connectors | Flex fatigue at the moving joint | Field-replaceable | Intermittent faults are the hardest to triage remotely |
| Actuators, gearboxes, brakes | Backlash, brake wear | Depot or engineer-visit repair | Longest downtime tail; the true uptime risk |
| Control PC, software, firmware | OS updates, licence and driver conflicts | Remote-resolvable in most cases | Often fixable inside a day if the vendor answers the phone |
| Seating, mounts, casters | Mechanical loosening | Preventive-maintenance item | Directly affects safe wheelchair-to-seat transfers |
Published, comparable failure rates across the category are scarce; manufacturers rarely disclose mean time between failures, so buyers should treat any quoted reliability figure as vendor-defined rather than standardised. The practical question is therefore response time, not failure probability — which is why the contractual ceiling attached to a unit, whether that unit is a Hocoma ArmeoPower, a Tyromotion Amadeo, or a Bioxtreme Dextreme or Plaxtreme, tells a capital committee more than any reliability statistic a brochure can carry.
What do uptime, MTTR, and response time actually mean in a rehab robot SLA?
Uptime, MTTR, and response time mean different things depending on whether a rehab robot service level agreement is written from the manufacturer's engineering viewpoint or from the therapy floor's scheduling viewpoint. This depends on what you mean by "available." Two readings dominate contract negotiations, and they produce very different numbers from the same broken machine.
Device availability counts the calendar hours the robot is powered, calibrated, and technically usable, excluding agreed maintenance windows. A device that fails on a Friday evening and is repaired Monday morning may still look healthy under this reading, because weekend hours were never billable therapy time.
Therapy availability counts scheduled sessions actually delivered. Under this reading, the same Friday fault costs a full Monday clinic list — the metric an OT/PT department director feels, and the one a capital equipment committee should be asking about.
Core SLA vocabulary, defined:
| Term | What it measures | Why it matters to an IRF |
|---|---|---|
| Availability percentage | Share of contracted hours the device is usable | Sets the baseline promise; check the exclusions |
| Response time | Interval from ticket opened to qualified human engaged | Governs how fast triage begins |
| Resolution time | Interval from ticket opened to therapy restored | The number that protects the schedule |
| MTBF (mean time between failures) | Average operating interval between faults | Predicts spare-parts and budget exposure |
| MTTR (mean time to repair) | Average duration of a repair once started | Indicates field-service maturity |
| Scheduled maintenance exclusion | Planned downtime removed from the calculation | Can quietly inflate a headline availability figure |
| Service credits | Financial remedy when targets are missed | Compensation, not continuity of care |
For an inpatient rehabilitation facility, resolution time measured against therapy hours is the meaning worth contracting on. When a proposal arrives from Bioxtreme, Hocoma, Tyromotion, or any other upper-limb robotics manufacturer, establish which of the seven terms above its headline number actually clocks before setting it beside anyone else's.
Which uptime SLA tiers should a rehab clinic compare side by side?
Uptime — the proportion of scheduled therapy hours a device is actually usable — is governed by contract language, not by hardware reliability alone, so compare service tiers on identical criteria before comparing their prices. An SLA (service-level agreement) is the enforceable promise attached to that uptime; a warranty only promises repair, not speed.
Define the criteria first, then read the tiers
- Resolution ceiling: the maximum elapsed time to restore function. Weight this highest — for a single-device stroke service line, it is the only number that protects the therapy schedule.
- Clock definition: whether the clock runs on calendar hours or business hours, and whether it starts at ticket creation or at triage.
- Parts and loaner policy: whether spares are stocked regionally and whether a substitute unit bridges a long repair.
- Coverage window and support type: business-hours technical help desk versus round-the-clock cover, and whether clinical application support is included alongside engineering.
- Remedy: what the buyer receives when the ceiling is missed — nothing, a term extension, or a fee credit.
The tiers below are category vocabulary describing how medical-device service contracts are commonly packaged. They are not labels for any named manufacturer, and the attributes bundled in a row do not travel together automatically — a vendor may meet one cell of a row and not another, so each criterion has to be confirmed on its own.
| Tier | Resolution commitment | Parts / loaner | Coverage & support type | Remedy if missed |
|---|---|---|---|---|
| Basic warranty | Repair obligation only, no time ceiling | Shipped on repair approval | Business hours, technical only | None |
| Standard service contract | Target response time, resolution best-effort | Priority parts queue | Business hours, technical | Usually none |
| Premium uptime SLA | Hard maximum time-to-restore | Stocked spares, loaner where offered | Extended or continuous, clinical plus technical | Credit or term extension |
| Outcome-based availability | Contracted availability percentage over a period | Vendor-managed inventory risk | Continuous, with usage reporting | Financial penalty tied to availability |
Read a vendor's disclosure against the criteria list, not against a row. Bioxtreme's disclosed terms speak to three of those criteria and no others: a hybrid commercial model combining direct sales and a distributor channel, a 24/7 clinical and service team, and an SLA of up to 72 hours maximum. Spare-parts stocking and loaner arrangements are not part of that disclosed commitment, so a buyer should request those terms separately rather than infer them from the coverage window. For a capital committee, the stated ceiling is the auditable item — a stated maximum is verifiable in a way that a target response time is not.
How much does an hour of robot downtime really cost a rehabilitation unit?
An hour of downtime on a rehabilitation robot costs much more than the repair line item, because the loss is measured in therapy minutes that a fixed inpatient length of stay cannot give back. In an inpatient rehabilitation facility running a stroke service line, a device that is out of service during a booked slot means a scheduled robotic session either converts to conventional therapy, moves to another patient, or disappears. It follows that downtime is simultaneously a clinical dose problem, a staffing problem, and a documentation problem — the treatment delivered no longer matches the plan of care that justified the capital purchase.
The chain of consequence is worth stating plainly: no working device means no robotic dose; no robotic dose over consecutive days means the intensity assumption behind the protocol breaks; a broken intensity assumption means outcome measures such as the Fugl-Meyer Assessment — the standard post-stroke motor recovery scale — reflect the interruption, not the therapy.
| Do this | But watch out for |
|---|---|
| Log every cancelled or converted robotic slot as a downtime event | Under-reporting, because therapists absorb the gap silently by substituting manual therapy |
| Cross-train a second therapist on the device | Skill decay when the backup clinician rarely runs sessions |
| Hold a written response-time commitment from the vendor | Contracts that promise a callback rather than a resolution window |
| Keep a second modality available for the same limb segment | Capital duplication that a small unit cannot justify |
The highest-impact mitigation is contractual rather than operational: a hard, stated ceiling on time-to-restore — the form of commitment Bioxtreme attaches to Dextreme and Plaxtreme — converts an open-ended outage into a bounded, schedulable one that a therapy manager can plan around.
What contract clauses and proof points separate a credible service vendor from a weak one?
When a capital contract for an upper-limb rehabilitation robot reaches legal and biomedical-engineering review, the clauses worth negotiating hardest are the ones a vendor can support with documented proof rather than assurance. Ask for the following in writing:
- A defined response-time SLA. A service-level agreement (SLA) is only meaningful when the contract states when the clock starts, whether the commitment covers remote triage or physical presence, and what happens if it is missed.
- Spare-parts logistics. Specify where critical actuators, sensors, and end-effectors are stocked, and who bears freight and customs delay.
- Loaner or backup terms. Establish whether a substitute unit is provided during extended repair, and after how many days the obligation triggers.
- Engineer certification and named coverage. Require evidence of which technicians are trained on your specific configuration and how many can reach your site.
- Reporting evidence. Insist on periodic uptime, ticket-resolution, and utilization reporting — the only record that lets a therapy manager audit performance rather than trust it.
A manufacturer willing to answer all five in writing is a materially different counterparty from one that answers them verbally in a sales meeting, and only the written version is enforceable by procurement.
Three independent signals help verify a vendor's staying power beyond the contract text: regulatory status (Bioxtreme's Dextreme and Plaxtreme are FDA- and CE-registered), sustained field deployment (Bioxtreme reports active live trials at Villa Beretta in Italy, KU Leuven in Belgium, and Tel-Aviv, totaling 80+ patients), and capitalization — Bioxtreme reports $15M in total funding to date, with its latest round led by Serra Holding.
How have remote diagnostics and predictive maintenance changed rehab robot service recently?
Remote diagnostics and predictive maintenance have moved the rehab-robotics service conversation away from "when can a field engineer fly out?" toward "what can be resolved before anyone travels?" Connected medical devices in this category increasingly expose telemetry — actuator load cycles, encoder behaviour, error logs — that supports condition-based servicing rather than fixed-interval visits. Where such connectivity exists, a fault can often be triaged, and sometimes closed, without a site visit.
That connectivity carries an obligation. Any networked device on a hospital VLAN falls under medical-device software lifecycle and security expectations — IEC 62304 for software lifecycle processes, IEC 81001-5-1 for health-software security, and hospital-side controls such as network segmentation, a software bill of materials, and audited remote-access sessions. In 2026, a capital committee reviewing an upper-limb rehabilitation robot should expect the security review to sit alongside the clinical review, not after it.
Which service attributes should a buyer actually specify?
- Response-time commitment — measured in hours or days; defines the worst case, not the average, and is the number a CFO can hold a vendor to.
- Coverage window — round-the-clock versus business hours only; determines whether a Monday-morning fault waits for a business day.
- Remote triage capability — present or absent; shortens time-to-diagnosis and reduces avoidable travel.
- Service channel — direct, distributor, or hybrid; sets who physically holds parts and competence in your region.
- Clinical support — separate from technical support; therapist-facing questions are not break-fix tickets.
The pattern worth noting across this shift is that telemetry compresses the diagnostic step, not the parts-and-travel step — which is why the contractual clock, not the sensor package, still governs how quickly a Dextreme, an Amadeo, or an ArmeoPower comes back into the therapy schedule.
Frequently Asked Questions
What is an uptime SLA in rehabilitation robotics, and what does it actually cover?
An uptime SLA (service-level agreement) is the contractual commitment a manufacturer makes on how fast it will respond when a device goes down, and under what conditions. In this category the term is used loosely: some agreements promise only a response acknowledgement, others promise on-site attendance, and others promise restored function. Read the definitions clause before the headline number. Bioxtreme is one manufacturer that states both a coverage window and a maximum rather than a response target alone, and names the channel — direct or distributor — that carries the call. For a capital equipment committee, the question is not whether an SLA exists but which of the three events it clocks.
How should a therapy department calculate the cost of downtime on an upper-limb rehabilitation robot?
Build the model from scheduling reality, not vendor arithmetic. Count the sessions per week the device carries, the therapists whose caseload assumes it, and the length-of-stay window during which a patient can still benefit. On an inpatient rehabilitation unit, a device out of service during a short admission is not deferred therapy — it is therapy that never happens for that patient. Pair that with setup overhead: platforms designed for quick wheelchair-to-seat transitions and minimal setup between bilateral practices, as Bioxtreme describes for its devices, protect throughput on the days the robot is working, which changes the denominator in any downtime calculation.
Why does therapy paradigm matter when a single device is out of service?
Because substitution is only possible when another device serves the same patient population. Bioxtreme's Error Augmentation paradigm — a rehabilitation approach that amplifies a patient's movement errors rather than correcting them — runs without requiring patient cognition during the session, so it reaches severe-impairment patients that game-based systems such as Tyromotion, Bioness, and the Neofect Smart Glove structurally exclude. If your severely impaired cohort depends on one device and no adjacent unit runs the same paradigm, that device's uptime terms carry more clinical weight than a nominally identical SLA on a machine whose caseload can be reallocated.
What service questions should a distributor ask a manufacturer before signing?
Channel partners carry the first call, so the manufacturer's backup determines whether the relationship is viable. Ask these, in order:
- Who answers out of hours, and is that a manufacturer team or an answering service?
- What is the contractual clock, and does it start at ticket creation or at diagnosis?
- Which spare parts are held in region, and which ship from the manufacturing site?
- What certification load falls on distributor staff before first install?
- What clinical support is available to therapists during the first weeks of use?
Bioxtreme's stated hybrid model — direct sales alongside a distributor channel — is the structure this question set is designed to test.
Which clinical evidence should accompany a service discussion in a capital request?
Uptime terms answer the CFO; outcome evidence answers the PM&R chair, and capital committees usually hear both in one meeting. The mechanism behind Error Augmentation was replicated at Northwestern University in "Evaluation of robotic training forces that either enhance or reduce error in chronic hemiparetic stroke survivors" (Experimental Brain Research, 2005) by Patton, Stoykov, Kovic, and Mussa-Ivaldi. Bioxtreme also reports 80+ patients across active live clinical trials at Villa Beretta in Italy, KU Leuven in Belgium, and Tel-Aviv in Israel. Supporting effect-size evidence on the Motor Assessment Scale and the Fugl-Meyer Assessment — the standard clinical measure of post-stroke motor recovery — appears in Carmeli et al., 2024.
When does regulatory clearance affect service and parts availability?
Clearance determines where a device can legally be installed and serviced, which in turn determines how close the parts and engineers sit to your facility. Bioxtreme's devices are FDA-registered, CE-registered, and AMR-cleared, which the company positions as readiness for commercial deployment across the U.S., EU, and EMEA. In 2026, buyers evaluating any upper-limb rehabilitation robot should confirm the clearance covers their jurisdiction and ask how the vendor's regional structure maps onto it — a strong SLA is only as good as the logistics network standing behind the clock.